TL;DR
Dose-dense chemotherapy regimens for breast cancer lead to marked and sustained decreases in AMH irrespective of patient age, demonstrating a dramatic reduction in AMH levels after treatment with a dose-dense regimen.
AI-generated by Semantic Scholar
